⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEXX News
Lexaria Bioscience Corp. Common Stock
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
New Lexia Survey Reveals COVID-Era Kindergarteners Enter School With Weaker Literacy, Attention, and Social-Emotional Skills
businesswire.com
LEXX
CMBM
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Provides Strategic Update
accessnewswire.com
LEXX
LEXXW
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
accessnewswire.com
LEXX
LEXXW
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
accessnewswire.com
LEXX
LEXXW